Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Loos

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Frontiers in Pediatrics|May 2, 2022
Safety of Therapeutic Apheresis in Children and AdolescentsChristina Taylan, Anne Schaaf, Corina Dorn, et al.
Scientific Reports|October 9, 2019
Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonismKarl E Johansson, Anne-Lie Ståhl, Ida Arvidsson, et al.
Plos Pathogens|February 27, 2015
A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesiclesAnne-lie Ståhl, Ida Arvidsson, Karl E Johansson, et al.
Frontiers in Pediatrics|April 3, 2023
Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1Sebastian Loos, Markus J Kemper, Kaja Schmaeschke, et al.
Transfusion Medicine Reviews|July 30, 2016
Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic SyndromeJan Beneke, Aleksej Sartison, Jan T Kielstein, et al.
Pediatric Nephrology (Berlin, Germany)|July 28, 2020
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysisVerena Klämbt, Charlotte Gimpel, Martin Bald, et al.
Pediatric Nephrology (Berlin, Germany)|September 23, 2021
Correction to: Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysisVerena Klämbt, Charlotte Gimpel, Martin Bald, et al.
Pediatric Nephrology (Berlin, Germany)|March 26, 2014
Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndromeAngela Bauer, Sebastian Loos, Carola Wehrmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2012
An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in childrenSebastian Loos, Thurid Ahlenstiel, Brigitta Kranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4Sebastian Loos, Wiebke Aulbert, Bernd Hoppe, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Pediatrics|May 2, 2022
Safety of Therapeutic Apheresis in Children and AdolescentsChristina Taylan, Anne Schaaf, Corina Dorn, et al.
Scientific Reports|October 9, 2019
Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonismKarl E Johansson, Anne-Lie Ståhl, Ida Arvidsson, et al.
Plos Pathogens|February 27, 2015
A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesiclesAnne-lie Ståhl, Ida Arvidsson, Karl E Johansson, et al.
Frontiers in Pediatrics|April 3, 2023
Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1Sebastian Loos, Markus J Kemper, Kaja Schmaeschke, et al.
Transfusion Medicine Reviews|July 30, 2016
Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic SyndromeJan Beneke, Aleksej Sartison, Jan T Kielstein, et al.
Pediatric Nephrology (Berlin, Germany)|July 28, 2020
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysisVerena Klämbt, Charlotte Gimpel, Martin Bald, et al.
Pediatric Nephrology (Berlin, Germany)|September 23, 2021
Correction to: Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysisVerena Klämbt, Charlotte Gimpel, Martin Bald, et al.
Pediatric Nephrology (Berlin, Germany)|March 26, 2014
Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndromeAngela Bauer, Sebastian Loos, Carola Wehrmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2012
An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in childrenSebastian Loos, Thurid Ahlenstiel, Brigitta Kranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4Sebastian Loos, Wiebke Aulbert, Bernd Hoppe, et al.
Pageof 4